{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:10:57Z","timestamp":1793481057443,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R25GM096955"],"award-info":[{"award-number":["R25GM096955"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008902","name":"Puerto Rico Science, Technology and Research Trust","doi-asserted-by":"crossref","award":["2017-00173"],"award-info":[{"award-number":["2017-00173"]}],"id":[{"id":"10.13039\/501100008902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Asthma is a chronic inflammatory and multifactorial respiratory tract disease. It affects over 18 million adults and 6 million children in the USA with Puerto Ricans showing the highest prevalence (12%\u201319%). This airways illness can be triggered by an environmental stimulus such as grass pollen, fungi spores, cockroaches allergens, dust mites metabolic compounds, and importantly, by environmental proteases such as trypsin and tryptase. Because of the pivotal role of proteases in the onset of asthma pathophysiology, we focused this study on the serine Protease Activated Receptor-2 (PAR-2), a G-protein-coupled receptor widely expressed in cells across the respiratory tract. Herein, we measured the activation of PAR-2 on primary pulmonary bronchial\/tracheal epithelial cells, human small airway epithelial cells, lung bronchial smooth muscle cells (with and without asthma). We tested human-derived eosinophils from 61 Puerto Rican participants (33 asthmatic and 28 non-asthmatic). As surrogate of PAR-2 activation or inhibition we used intracellular calcium mobilization assay. We hypothesized that following exposure of the PAR-2 agonist (AC264613), the studied human primary cell types will increase the mobilization of intracellular calcium levels. In contrast, we expected a decrease of the intracellular calcium levels upon exposure to a PAR-2 antagonist (FSLLRY-NH2). The Puerto Rican-derived eosinophils were analyzed for the proinflammatory markers MAPK\/PI3K using flow cytometry (n\u200a=\u200a8). As expected, the PAR-2 agonist significantly increased the activation of PAR-2 on the bronchial\/tracheal epithelial cells, bronchial smooth muscle cells and human small airway epithelial cells (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01). The PAR-2 antagonist significantly decreased the intracellular calcium levels of these lung primary down to undetectable levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01). Remarkably, the asthmatic-derived eosinophils showed a striking 300% increase of intracellular calcium mobilization suggesting a severe response to the PAR-2 agonist stimuli in asthmatics. In contrast, there were no significant changes between groups after adding the PAR-2 antagonist. Our outcomes revealed that PAR-2 antagonist effectively inhibited the studied primary cells, expecting to decrease the immune response of eosinophils. Most importantly, our results reveal a promising role for the PAR-2 antagonist in targeting bronchial\/tracheal epithelial cells, human small airway epithelial cells and bronchial smooth muscle cells with the potential to oblige an asthma adjuvant therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022351","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:03:19Z","timestamp":1603501399000},"page":"e22351","source":"Crossref","is-referenced-by-count":9,"title":["Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy"],"prefix":"10.1097","volume":"99","author":[{"given":"Marinel","family":"Ocasio-Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Marin-Maldonado","sequence":"additional","affiliation":[{"name":"Ponce Health Science University, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraline","family":"Trossi-Torres","sequence":"additional","affiliation":[{"name":"University of Puerto Rico-Ponce, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angely","family":"Ortiz-Rosado","sequence":"additional","affiliation":[{"name":"University of Puerto Rico-Ponce, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Rodr\u00edguez-Irizarry","sequence":"additional","affiliation":[{"name":"University of Puerto Rico-Ponce, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[{"name":"University of Puerto Rico-Ponce, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahayra","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"University of Puerto Rico-Ponce, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharilyn","family":"Almod\u00f3var","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Science Center, Lubbock, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edu","family":"Suarez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"University of Puerto Rico-Ponce, Ponce Puerto Rico"},{"name":"Ponce Health Science University, Ponce Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1164\/rccm.200309-1293OC","article-title":"Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma","volume":"169","author":"Burchard","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20230916","first-page":"113","article-title":"An estimate of the prevalence, severity and seasonality of asthma in visitors to a Ponce shopping center","volume":"15","author":"Montealegre","year":"1996","journal-title":"P R Health Sci J"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1189\/jlb.0702351","article-title":"Expression of and functional responses to protease-activated receptors on human eosinophils","volume":"74","author":"Bolton","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.4049\/jimmunol.170.11.5690","article-title":"Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2","volume":"170","author":"Uehara","year":"2003","journal-title":"J Immunol"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"L1339","DOI":"10.1152\/ajplung.00392.2001","article-title":"Human bronchial epithelial cells express PAR-2 with different sensitivity to thermolysin","volume":"282","author":"Ubl","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1152\/jappl.2001.91.3.1372","article-title":"Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells","volume":"91","author":"Berger","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"L1369","DOI":"10.1152\/ajplung.2001.281.6.L1369","article-title":"Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle","volume":"281","author":"Chambers","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10520290009064152","article-title":"Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade","volume":"75","author":"D\u2019Andrea","year":"2000","journal-title":"Biotech Histochem"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.169.9.5315","article-title":"Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway","volume":"169","author":"Schmidlin","year":"2002","journal-title":"J Immunol"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1164\/ajrccm.161.5.9907133","article-title":"Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways","volume":"161","author":"Ricciardolo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1152\/physrev.00028.2003","article-title":"Protease-activated receptors: contribution to physiology and disease","volume":"84","author":"Ossovskaya","year":"2004","journal-title":"Physiol Rev"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","article-title":"Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb J"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10565-016-9353-x","article-title":"Expression of proteinase-activated receptor (PAR)-2 in monocytes from allergic patients and potential molecular mechanism","volume":"32","author":"Ge","year":"2016","journal-title":"Cell Biol Toxicol"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/JMAU.JMAU_55_18","article-title":"Effect of Protease-Activated Receptor-2-Activating Peptide on Guinea Pig Airway Resistance and Isolated Tracheal Strips","volume":"8","author":"Hagras","year":"2020","journal-title":"J Microsc Ultrastruct"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/imm.12453","article-title":"Proteinase activated receptor-2-mediated dual oxidase-2 up-regulation is involved in enhanced airway reactivity and inflammation in a mouse model of allergic asthma","volume":"145","author":"Nadeem","year":"2015","journal-title":"Immunology"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1067\/mai.2001.119025","article-title":"Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma","volume":"108","author":"Knight","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2015.12.1332","article-title":"Airway smooth muscle enlargement is associated with protease-activated receptor 2\/ligand overexpression in patients with difficult-to-control severe asthma","volume":"138","author":"Aubier","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"C718","DOI":"10.1152\/ajpcell.00257.2014","article-title":"A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductance","volume":"307","author":"Sherwood","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/acsmedchemlett.5b00429","article-title":"Potent Small Agonists of Protease Activated Receptor 2","volume":"7","author":"Yau","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/BJ20041066","article-title":"The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells","volume":"388","author":"Wilson","year":"2005","journal-title":"Biochem J"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1067\/mai.2003.1332","article-title":"Human eosinophils are activated by cysteine proteases and release inflammatory mediators","volume":"111","author":"Miike","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1042\/bst0311191","article-title":"Protease-activated receptor 2: activation, signalling and function","volume":"31","author":"Cottrell","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yexmp.2015.03.018","article-title":"Protease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K\/AKT signaling pathway","volume":"98","author":"Sun","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.iac.2007.09.008","article-title":"Asthma biomarkers in sputum","volume":"27","author":"Spahn","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1083\/jcb.148.6.1267","article-title":"beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1\/2","volume":"148","author":"DeFea","year":"2000","journal-title":"J Cell Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:46:28Z","timestamp":1694835988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":25,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022351","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}